Virtus Health Ltd
ASX:VRT
Virtus Health Ltd
ASX:VRT
Price:
8.1
AUD
Market Cap:
AU$705.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Virtus Health Ltd
ASX:VRT
|
AU |
|
C
|
Combined Motor Holdings Ltd
JSE:CMH
|
ZA |
|
Sichuan Etrol Technologies Co Ltd
SZSE:300370
|
CN |
|
C
|
Chengdu Huasun Technology Group Co Ltd
SZSE:000790
|
CN |
|
Insperity Inc
NYSE:NSP
|
US |
|
R
|
R R Kabel Ltd
NSE:RRKABEL
|
IN |
|
C
|
Concha y Toro Winery Inc
SGO:CONCHATORO
|
CL |
|
Kojima Co Ltd
TSE:7513
|
JP |
|
Biglari Holdings Inc
NYSE:BH.A
|
US |
|
Repsol SA
LSE:0NQG
|
ES |
Balance Sheet
Balance Sheet Decomposition
Virtus Health Ltd
Virtus Health Ltd
Balance Sheet Decomposition is not available for
Virtus Health Ltd
Virtus Health Ltd
Balance Sheet
Virtus Health Ltd
Virtus Health Ltd
Currency: AUD
| Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
9
|
13
|
22
|
18
|
22
|
27
|
22
|
19
|
38
|
37
|
|
| Cash |
9
|
13
|
22
|
18
|
22
|
27
|
22
|
19
|
38
|
37
|
|
| Total Receivables |
9
|
11
|
13
|
14
|
11
|
12
|
12
|
15
|
13
|
12
|
|
| Accounts Receivables |
6
|
7
|
11
|
11
|
10
|
10
|
11
|
11
|
9
|
9
|
|
| Other Receivables |
3
|
5
|
2
|
2
|
1
|
2
|
2
|
4
|
4
|
3
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Current Assets |
1
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
5
|
|
| Total Current Assets |
19
|
25
|
36
|
34
|
36
|
43
|
38
|
38
|
56
|
55
|
|
| PP&E Net |
23
|
27
|
28
|
31
|
30
|
29
|
34
|
38
|
125
|
109
|
|
| PP&E Gross |
23
|
27
|
28
|
31
|
30
|
29
|
34
|
38
|
125
|
109
|
|
| Accumulated Depreciation |
17
|
22
|
29
|
41
|
50
|
58
|
68
|
73
|
95
|
116
|
|
| Intangible Assets |
8
|
6
|
10
|
12
|
12
|
12
|
12
|
11
|
9
|
6
|
|
| Goodwill |
304
|
319
|
346
|
379
|
387
|
400
|
453
|
448
|
425
|
422
|
|
| Long-Term Investments |
4
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
4
|
7
|
9
|
8
|
6
|
5
|
6
|
7
|
11
|
12
|
|
| Other Assets |
304
|
319
|
346
|
379
|
387
|
400
|
453
|
448
|
425
|
422
|
|
| Total Assets |
362
N/A
|
386
+7%
|
430
+11%
|
465
+8%
|
473
+2%
|
490
+4%
|
545
+11%
|
544
0%
|
626
+15%
|
605
-3%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
6
|
7
|
10
|
10
|
10
|
9
|
10
|
8
|
12
|
11
|
|
| Accrued Liabilities |
5
|
0
|
2
|
3
|
3
|
4
|
4
|
5
|
4
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
14
|
0
|
0
|
0
|
0
|
14
|
0
|
1
|
11
|
13
|
|
| Other Current Liabilities |
15
|
16
|
21
|
21
|
21
|
21
|
34
|
43
|
62
|
50
|
|
| Total Current Liabilities |
41
|
23
|
34
|
34
|
34
|
48
|
49
|
57
|
90
|
79
|
|
| Long-Term Debt |
89
|
144
|
139
|
152
|
147
|
154
|
184
|
176
|
258
|
216
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Minority Interest |
0
|
0
|
10
|
19
|
19
|
20
|
10
|
10
|
1
|
2
|
|
| Other Liabilities |
7
|
4
|
17
|
33
|
34
|
20
|
29
|
16
|
10
|
9
|
|
| Total Liabilities |
137
N/A
|
171
+25%
|
200
+17%
|
238
+19%
|
235
-1%
|
241
+3%
|
272
+13%
|
260
-4%
|
359
+38%
|
306
-15%
|
|
| Equity | |||||||||||
| Common Stock |
185
|
232
|
237
|
238
|
239
|
242
|
242
|
242
|
241
|
242
|
|
| Retained Earnings |
40
|
17
|
7
|
10
|
1
|
7
|
28
|
38
|
22
|
54
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Equity |
0
|
0
|
1
|
1
|
1
|
0
|
3
|
4
|
5
|
2
|
|
| Total Equity |
225
N/A
|
215
-5%
|
229
+7%
|
227
-1%
|
239
+5%
|
249
+4%
|
273
+10%
|
284
+4%
|
267
-6%
|
299
+12%
|
|
| Total Liabilities & Equity |
362
N/A
|
386
+7%
|
430
+11%
|
465
+8%
|
473
+2%
|
490
+4%
|
545
+11%
|
544
0%
|
626
+15%
|
605
-3%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
54
|
80
|
80
|
80
|
80
|
80
|
80
|
80
|
80
|
80
|
|
Switch to:
Switch to:
See Also
Discover More
